242 related articles for article (PubMed ID: 23669379)
1. Nanoscale effects of caspofungin against two yeast species, Saccharomyces cerevisiae and Candida albicans.
Formosa C; Schiavone M; Martin-Yken H; François JM; Duval RE; Dague E
Antimicrob Agents Chemother; 2013 Aug; 57(8):3498-506. PubMed ID: 23669379
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulence.
Rueda C; Cuenca-Estrella M; Zaragoza O
Antimicrob Agents Chemother; 2014; 58(2):1071-83. PubMed ID: 24295973
[TBL] [Abstract][Full Text] [Related]
3. Escape of Candida from caspofungin inhibition at concentrations above the MIC (paradoxical effect) accomplished by increased cell wall chitin; evidence for beta-1,6-glucan synthesis inhibition by caspofungin.
Stevens DA; Ichinomiya M; Koshi Y; Horiuchi H
Antimicrob Agents Chemother; 2006 Sep; 50(9):3160-1. PubMed ID: 16940118
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin-induced β(1,3)-glucan exposure in
Wagner AS; Lumsdaine SW; Mangrum MM; Reynolds TB
mBio; 2023 Aug; 14(4):e0007423. PubMed ID: 37377417
[TBL] [Abstract][Full Text] [Related]
5. A Candida albicans strain with high MIC for caspofungin and no FKS1 mutations exhibits a high chitin content and mutations in two chitinase genes.
Drakulovski P; Dunyach C; Bertout S; Reynes J; Mallié M
Med Mycol; 2011 Jul; 49(5):467-74. PubMed ID: 21108572
[TBL] [Abstract][Full Text] [Related]
6. Emodin Reduces the Activity of (1,3)-
Janeczko M
Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232
[TBL] [Abstract][Full Text] [Related]
7. Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment.
Wheeler RT; Kombe D; Agarwala SD; Fink GR
PLoS Pathog; 2008 Dec; 4(12):e1000227. PubMed ID: 19057660
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
[TBL] [Abstract][Full Text] [Related]
9. Changes in cell wall synthesis and ultrastructure during paradoxical growth effect of caspofungin on four different Candida species.
Bizerra FC; Melo AS; Katchburian E; Freymüller E; Straus AH; Takahashi HK; Colombo AL
Antimicrob Agents Chemother; 2011 Jan; 55(1):302-10. PubMed ID: 21060107
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity.
Plaine A; Walker L; Da Costa G; Mora-Montes HM; McKinnon A; Gow NA; Gaillardin C; Munro CA; Richard ML
Fungal Genet Biol; 2008 Oct; 45(10):1404-14. PubMed ID: 18765290
[TBL] [Abstract][Full Text] [Related]
11. Identification of New Antifungal Agents Targeting Chitin Synthesis by a Chemical-Genetic Method.
Li Y; Sun H; Zhu X; Bian C; Wang Y; Si S
Molecules; 2019 Aug; 24(17):. PubMed ID: 31470665
[TBL] [Abstract][Full Text] [Related]
12. Nanoscale analysis of caspofungin-induced cell surface remodelling in Candida albicans.
El-Kirat-Chatel S; Beaussart A; Alsteens D; Jackson DN; Lipke PN; Dufrêne YF
Nanoscale; 2013 Feb; 5(3):1105-15. PubMed ID: 23262781
[TBL] [Abstract][Full Text] [Related]
13. Reshuffling of Aspergillus fumigatus cell wall components chitin and β-glucan under the influence of caspofungin or nikkomycin Z alone or in combination.
Verwer PE; van Duijn ML; Tavakol M; Bakker-Woudenberg IA; van de Sande WW
Antimicrob Agents Chemother; 2012 Mar; 56(3):1595-8. PubMed ID: 22203603
[TBL] [Abstract][Full Text] [Related]
14. Highly Dynamic and Specific Phosphatidylinositol 4,5-Bisphosphate, Septin, and Cell Wall Integrity Pathway Responses Correlate with Caspofungin Activity against Candida albicans.
Badrane H; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3591-600. PubMed ID: 27021331
[TBL] [Abstract][Full Text] [Related]
15. Nanoscopic cell-wall architecture of an immunogenic ligand in Candida albicans during antifungal drug treatment.
Lin J; Wester MJ; Graus MS; Lidke KA; Neumann AK
Mol Biol Cell; 2016 Mar; 27(6):1002-14. PubMed ID: 26792838
[TBL] [Abstract][Full Text] [Related]
16. Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofungin.
Badrane H; Nguyen MH; Blankenship JR; Cheng S; Hao B; Mitchell AP; Clancy CJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4614-24. PubMed ID: 22687514
[TBL] [Abstract][Full Text] [Related]
17. AFM combined to ATR-FTIR reveals Candida cell wall changes under caspofungin treatment.
Quilès F; Accoceberry I; Couzigou C; Francius G; Noël T; El-Kirat-Chatel S
Nanoscale; 2017 Sep; 9(36):13731-13738. PubMed ID: 28884772
[TBL] [Abstract][Full Text] [Related]
18. Synergy of the antibiotic colistin with echinocandin antifungals in Candida species.
Zeidler U; Bougnoux ME; Lupan A; Helynck O; Doyen A; Garcia Z; Sertour N; Clavaud C; Munier-Lehmann H; Saveanu C; d'Enfert C
J Antimicrob Chemother; 2013 Jun; 68(6):1285-96. PubMed ID: 23378416
[TBL] [Abstract][Full Text] [Related]
19. Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.
Lee KK; Maccallum DM; Jacobsen MD; Walker LA; Odds FC; Gow NA; Munro CA
Antimicrob Agents Chemother; 2012 Jan; 56(1):208-17. PubMed ID: 21986821
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin-induced in-vitro post-antifungal effect and its impact on adhesion related traits of oral Candida dubliniensis and Candida albicans isolates.
Ellepola AN; Chandy R; Khan ZU; Samaranayake LP
Microbiol Immunol; 2016 Mar; 60(3):160-7. PubMed ID: 26850765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
